Skip to content

Study · Not a test of the peptide alone · 2016

2 results

Insulinotropic action of bombesin-like peptides mediated by gastrin-releasing peptide receptors in steers.

Zhao HQ, Yao G, Yannaing S, ThanThan S, Kuwayama H

Journal of animal science1 Jan 2016

PMID26812312 (opens in a new tab)DOI10.2527/jas.2015-9495 (opens in a new tab)PepBankPUB-26812312
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking GHRP-6.

  1. 01AnimalNot a test of GHRP-6 aloneAnimal study (in vivo)Mechanism

    In Holstein steers, the GHS-R1a antagonist [D-Lys]-GHRP‑6 did not block the insulin changes induced by neuromedin C.

    In plain wordsIn steers, a ghrelin-receptor blocker did not stop the rise in insulin caused by neuromedin C.

    Peptide
    GHRP-6
    Outcome
    No significant changeNeuromedin C-induced insulin change with GHS-R1a antagonist
    Study

    Holstein steern = 8

    Comparator
    Neuromedin C alone
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones

    Source sentences

    Summary
    The NMC-induced changes of insulin and glucose were completely blocked by N-GRP-EE
    2 context sentences
    Summary · context
    but [D-Lys]-GHRP-6 did not block any of these changes.
    Summary · context
    Eight Holstein steers were randomly and intravenously injected with synthetic bovine gastrin-releasing peptide (GRP; 0.9 nmol/kg BW), neuromedin B (NMB; 0.9 nmol/kg BW), or neuromedin C (NMC; 0.9 nmol/kg BW)

    In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-6.

  2. 02AnimalNot a test of GHRP-6 aloneAnimal study (in vivo)Mechanism

    In Holstein steers, the GHS-R1a antagonist [D-Lys]-GHRP‑6 did not block the glucose changes induced by neuromedin C.

    In plain wordsIn steers, a ghrelin-receptor blocker did not stop the change in blood glucose caused by neuromedin C.

    Peptide
    GHRP-6
    Outcome
    No significant changeNeuromedin C-induced glucose change with GHS-R1a antagonist
    Study

    Holstein steern = 8

    Comparator
    Neuromedin C alone
    Outcome group
    Receptor activity and mechanism · Endocrine and hormones

    Source sentences

    Summary
    The NMC-induced changes of insulin and glucose were completely blocked by N-GRP-EE
    2 context sentences
    Summary · context
    but [D-Lys]-GHRP-6 did not block any of these changes.
    Summary · context
    Eight Holstein steers were randomly and intravenously injected with synthetic bovine gastrin-releasing peptide (GRP; 0.9 nmol/kg BW), neuromedin B (NMB; 0.9 nmol/kg BW), or neuromedin C (NMC; 0.9 nmol/kg BW)

    In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-6.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 12:58 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:13 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.